@article{70a1272c0275406b88b5ddf45abf8aae,
title = "HDAC2 as a new target to improve schizophrenia treatment",
keywords = "5-HT receptor, G protein-coupled receptor, antipsychotic drugs, epigenetics, histone deacetylase, metabotropic glutamate 2 receptor, schizophrenia, serotonin",
author = "Mitsumasa Kurita and Terrell Holloway and Javier Gonz{\'a}lez-Maeso",
note = "Funding Information: The authors were supported by NIH grant R01 MH084894 and Dainippon Sumitomo Pharma. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",
year = "2013",
month = jan,
doi = "10.1586/ern.12.141",
language = "English",
volume = "13",
pages = "1--3",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Taylor and Francis Ltd.",
number = "1",
}